N
NeurAxis, Inc. (NRXS)
ASE – Real Time Price. Currency in USD
8.27
+0.12 (1.47%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
8.27
+0.12 (1.47%)
At close: May 12, 2026, 4:00 PM EDT
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
| Name | Position |
|---|---|
| Dr. Adrian Miranda | Senior VP of Science & Technology and Chief Medical Officer |
| Dr. Christopher Robin Brown D.D.S. | Founder, Director of Innovation & Director |
| Dr. Thomas Carrico | Chief Regulatory Officer and Compliance & Privacy Officer |
| Mr. Behnam Shamsian CPA | Investor Relations |
| Mr. Brian Carrico | President, CEO & Director |
| Mr. Timothy Robert Henrichs | Chief Financial Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-12 | 10-Q | form10-q.htm |
| 2026-04-28 | DEFA14A | ny20066493x2_defa14a.htm |
| 2026-04-28 | ARS | formars.pdf |
| 2026-04-22 | 8-K | form8-k.htm |
| 2026-04-21 | 8-K | form8-k.htm |
| 2026-03-19 | 10-K | form10-k.htm |
| 2025-11-10 | 10-Q | form10-q.htm |
| 2025-10-24 | 8-K | form8-k.htm |
| 2025-10-23 | 8-K | form8-k.htm |
| 2025-10-08 | S-8 | forms-8.htm |